Animal Carcinogenicity Studies: 1. Poor Human Predictivity

The regulation of human exposure to potentially carcinogenic chemicals constitutes society's most important use of animal carcinogenicity data. Environmental contaminants of greatest concern within the USA are listed in the Environmental Protection Agency's (EPA's) Integrated Risk Information System (IRIS) chemicals database. However, of the 160 IRIS chemicals lacking even limited human exposure data but possessing animal data that had received a human carcinogenicity assessment by 1 January 2004, we found that in most cases (58.1%; 93/160), the EPA considered animal carcinogenicity data inadequate to support a classification of probable human carcinogen or non-carcinogen. For the 128 chemicals with human or animal data also assessed by the World Health Organisation's International Agency for Research on Cancer (IARC), human carcinogenicity classifications were compatible with EPA classifications only for those 17 having at least limited human data (p = 0.5896). For those 111 primarily reliant on animal data, the EPA was much more likely than the IARC to assign carcinogenicity classifications indicative of greater human risk (p < 0.0001). The IARC is a leading international authority on carcinogenicity assessments, and its significantly different human carcinogenicity classifications of identical chemicals indicate that: 1) in the absence of significant human data, the EPA is over-reliant on animal carcinogenicity data; 2) as a result, the EPA tends to over-predict carcinogenic risk; and 3) the true predictivity for human carcinogenicity of animal data is even poorer than is indicated by EPA figures alone. The EPA policy of erroneously assuming that tumours in animals are indicative of human carcinogenicity is implicated as a primary cause of these errors.

[1]  L. Gold,et al.  Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996. , 1999, Environmental health perspectives.

[2]  Iarc Monograhs,et al.  3. Studies of Cancer in Experimental Animals , 2008 .

[3]  L. Gold,et al.  Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  S. Epstein The politics of cancer revisited , 1998 .

[5]  C. Coggins National Toxicology Program '"Report on Carcinogens (Ninth Edition)": Environmental Tobacco Smoke , 1998 .

[6]  Will all chemicals be carcinogenic to rodents when adequately evaluated? , 1993, Mutagenesis.

[7]  B. Ames,et al.  What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.

[8]  P. Sandercock,et al.  Where is the evidence that animal research benefits humans? , 2004, BMJ : British Medical Journal.

[9]  Epstein,et al.  The politics of cancer , 2000, JAMA.

[10]  J Ashby,et al.  Alternatives to the 2-species bioassay for the identification of potential human carcinogens , 1996, Human & experimental toxicology.

[11]  V. Beral,et al.  IARC MONOGRAPHS PROGRAMME ON THE EVALUATION OF CARelNOGENIC RISKS TO HUMANS' , 2008 .

[12]  F. M. Johnson Response to Tennant et al.: Attempts to replace the NTP rodent bioassay with transgenic alternatives are unlikely to succeed , 2001 .

[13]  Shelly Puleo US Environmental Protection Agency , 1982 .

[14]  W. Viscusi,et al.  Synthetic risks, risk potency, and carcinogen regulation. , 1998, Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management].

[15]  A. Monro,et al.  Evaluation of the Carcinogenic Potential of Pharmaceuticals , 1998, Drug safety.

[16]  M. Pike,et al.  The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984, Environmental health perspectives.

[17]  S. Fukushima,et al.  Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. , 1984, Journal of the National Cancer Institute.

[18]  Lester B Lave,et al.  Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity. , 2003, Regulatory toxicology and pharmacology : RTP.

[19]  F. K. Ennever,et al.  The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. , 1987, Mutagenesis.

[20]  J. Huff,et al.  The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. , 1995, Environmental health perspectives.

[21]  Thomas H. Parker,et al.  What is π , 1991 .

[22]  J. Huff,et al.  Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.

[23]  D. Rall LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.

[24]  G. Swaen,et al.  The predictive value of animal data in human cancer risk assessment. , 1997, Regulatory toxicology and pharmacology : RTP.

[25]  A. Aitio,et al.  Human Carcinogens So Far Identified , 1989, Japanese journal of cancer research : Gann.

[26]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[27]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .

[28]  M. Stephens,et al.  Unrelieved pain and distress in animals: an analysis of USDA data on experimental procedures. , 1998, Journal of applied animal welfare science : JAAWS.

[29]  U. Epa Guidelines for carcinogen risk assessment , 1986 .

[30]  J. Kaldor,et al.  Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. , 1986, Carcinogenesis.

[31]  L. Bernstein,et al.  Interspecies extrapolation in carcinogenesis: prediction between rats and mice. , 1989, Environmental health perspectives.

[32]  A. Monro Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[33]  J K Haseman,et al.  USING THE NTP DATABASE TO ASSESS THE VALUE OF RODENT CARCINOGENICITY STUDIES FOR DETERMINING HUMAN CANCER RISK , 2000, Drug metabolism reviews.